Full name
INSTYTUT GENETYKI I IMMUNOLOGII GENIM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
INSTYTUT GENETYKI I IMMUNOLOGII GENIM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. FILARETÓW 27 / 2, 20-609 LUBLIN
TAX ID7123230592
Rate company:
INSTYTUT GENETYKI I IMMUNOLOGII GENIM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7123230592
KRS0000369181
Share capital10,000.00 zł
address
UL. FILARETÓW 27 / 2, 20-609 LUBLIN
Website
www.genim.c0.plCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7123230592
REGON
060695099
KRS
0000369181
Legal form
limited liability company
Register Address
UL. FILARETÓW 27 / 2, 20-609 LUBLIN
Date of registration in KRS
2010-10-28
Date of commencement of economic activity
2010-10-28
Act signature
LU.VI NS-REJ.KRS/682/25/993/ADE
Website
WWW.GENIM.C0.PL
Pkd codes
86.91.B - Medical laboratory activities
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
58 - Publishing activities
68 - Real estate activities
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
85 - Education
86 - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL74 1750 0012 0000 0000 3758 7338 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,5 | 0,4 | 0,7 | 53,2 |
Gross profit (loss) | 0,5 | 0,5 | 0,7 | 53,5 |
EBITDA | 0,6 | 0,6 | 0,7 | 16,3 |
Short time liabilities | 0,3 | 0,2 | 0,2 | 25,7 |
Other operating costs | 0 | 0 | 0 | 265 |
Equity capital | 3,5 | 3,3 | 3,5 | 6,9 |
Operating profit (EBIT) | 0,5 | 0,4 | 0,7 | 51,5 |
Assets | 3,8 | 3,5 | 3,7 | 7,9 |
Net profit (loss) | 0,4 | 0,4 | 0,6 | 53,2 |
Cash | 2,1 | 2,2 | 2,1 | -5,3 |
Net income from sale | 3,6 | 3,6 | 5,4 | 48,6 |
Liabilities and provisions for liabilities | 0,3 | 0,2 | 0,2 | 25,7 |
Working assets | 2,9 | 2,7 | 2,9 | 9,8 |
Other income costs | 0 | 0 | 0 | 62 |
Depreciation | 0,1 | 0,2 | 0 | -86,4 |
% | % | % | p.p. | |
Profitability of capital | 12,7 | 12,5 | 17,9 | 5,4 |
Equity capital to total assets | 91,3 | 95,1 | 94,3 | -0,8 |
Gross profit margin | 13,4 | 12,4 | 12,8 | 0,4 |
EBITDA Margin | 17,2 | 16,2 | 12,6 | -3,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 17 | 14 | -3 |
Current financial liquidity indicator | 8.879937171936035 | 15.854464530944824 | 13.846394538879395 | -2,1 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Lubuski Instytut Psychoterapii i Kreatywności - Dialog
Gorzów Wielkopolski
EWA PRZYWARA
Kraków
SUKURS
Gdańsk
PORADNIA MEDYCYNY ŻYWIENIA MEDFOOD
BYDGOSZCZ
Paweł Cisowski Mindverd
Warszawa
Pracownia Psychologii Pracy
Ostrowiec Świętokrzyski